GlaxoSmithKline pulls all U.S. alli supplies, launches product-tampering probe

Carly Helfand

is recalling of its OTC weight-loss drug in light of reports from consumers who found the wrong drug when they opened their bottles.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS